A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates

Journal of Clinical Investigation

Volumn 120, Issue 4, 2010, Pages 1125-1139

  Blin, Guillaume ^a,b   Nury, David ^a   Stefanovic, Sonia ^a   Neri, Tui ^a   Guillevic, Oriane ^a   Brinon, Benjamin ^a   Bellamy, Valérie ^a   Rücker Martin, Catherine ^c   Barbry, Pascal ^c   Bel, Alain ^d   Bruneval, Patrick ^d   Cowan, Chad ^e   Pouly, Julia ^d   Mitalipov, Shoukhrat ^f   Gouadon, Elodie ^c   Binder, Patrice ^g   Hagège, Albert ^a,d   Desnos, Michel ^a,d   Renaud, Jean François ^c   Menasché, Philippe ^a,d   Pucéat, Michel ^a,h   more..

^a INSERM   (France)

^b UNIV MONTPELLIER   (France)

^c CNRS   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g Institut de Medecine Aerospatiale du Service de Sante des Armees   (France)

^h Parc Scientifique de Luminy   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BONE MORPHOGENETIC PROTEIN 2; MESODERM POSTERIOR 1 ANTIGEN; MICRORNA; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CELL POPULATION; CLONOGENIC ASSAY; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; ENGRAFTMENT; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIMATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCAR; SEQUENCE ANALYSIS; SMOOTH MUSCLE FIBER; STEM CELL; TERATOMA;

ANIMALS; ANTIGENS, CD15; ANTIGENS, CD31; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MACACA MULATTA; MICRORNAS; MULTIPOTENT STEM CELLS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; OCTAMER TRANSCRIPTION FACTOR-3; STEM CELL TRANSPLANTATION;

EID: 77951181560     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI40120     Document Type: Article

References (63)

1. Rudnick D. Differentiation in culture of pieces of early chick blastoderm. Ann N Y Acad Sci. 1938;49:761-772.
2. Tam PPL, Schoenwolf G. Cardiac fate map: lineage, allocation, morphogenetic movement and cell commitment. In: Harvey RP, Rosenthal N, eds. Heart Development. San Diego, CA: Academic Press; 1999:3-18.
3. Hendrikx M, et al. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation. 2006;114(1 Suppl):I101-I107.
4. Menasche P, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation. 2008; 117(9):1189-1200.
5. Pouly J, et al. Cardiac stem cells in the real world. J Thorac Cardiovasc Surg. 2008;135(3):673-678.
6. Roy NS, et al. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med. 2006;12(11):1259-1268.
7. Laflamme MA, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol. 2007;25(9):1015-1024.
8. Caspi O, et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol. 2007;50(19):1884-1893.
9. Van Laake LW, Passier R, Doevendans PA, Mummery CL. Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res. 2008;102(9):1008-1010.
10. Passier R, van Laake LW, Mummery CL. Stem-cellbased therapy and lessons from the heart. Nature. 2008;453(7193):322-329.
11. Garry DJ, Olson EN. A common progenitor at the heart of development. Cell. 2006;127(6):1101-1104.
12. Moretti A, et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell. 2006; 127(6):1151-1165.
13. Ma Q, Zhou B, Pu WT. Reassessment of Isl1 and Nkx2-5 cardiac fate maps using a Gata4-based reporter of Cre activity. Dev Biol. 2008;323(1):98-104.
14. Kattman SJ, Huber TL, Keller GM. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell. 2006;11(5):723-732.
15. Yang L, et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature. 2008;453(7194):524-528.
16. Crease DJ, Dyson S, Gurdon JB. Cooperation between the activin and Wnt pathways in the spatial control of organizer gene expression. Proc Natl Acad Sci U S A. 1998;95(8):4398-4403.
17. Bakre MM, et al. Generation of multipotential mesendodermal progenitors from mouse embryonic stem cells via sustained Wnt pathway activation. J Biol Chem. 2007;282(43):31703-31712.
18. Tomescot A, et al. Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats. Stem Cells. 2007; 25(9):2200-2205.
19. Stefanovic S, Abboud N, Desilets S, Nury D, Cowan C, Puceat M. Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate. J Cell Biol. 2009; 186(5):665-673.
20. Henderson JK, et al. Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells. 2002;20(4):329-337.
21. Leschik J, Stefanovic S, Brinon B, Puceat M. Cardiac commitment of primate embryonic stem cells. Nature Protocols. 2008;3(9):1381-1387.
22. Stefanovic S, Puceat M. Oct-3/4: not just a gate-keeper of pluripotency for embryonic stem cell, a cell fate instructor through a gene dosage effect. Cell Cycle. 2007;6(1):8-10.
23. Bondue A, et al. Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell. 2008;3(1):69-84.
24. Christiaen L, Stolfi A, Davidson B, Levine M. Spatio-temporal intersection of Lhx3 and Tbx6 defines the cardiac field through synergistic activation of Mesp. Dev Biol. 2009;328(2):552-560.
25. Cai CL, et al. A myocardial lineage derives from Tbx18 epicardial cells. Nature. 2008;454(7200):104-108.
26. Franco D, et al. Left and right ventricular contributions to the formation of the interventricular septum in the mouse heart. Dev Biol. 2006;294(2):366-375.
27. Horsthuis T, et al. Gene expression profiling of the forming atrioventricular node using a novel tbx3- based node-specific transgenic reporter. Circ Res. 2009;105(1):61-69.
28. Bernstein BE, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell. 2006;125(2):315-326.
29. Stock JK, et al. Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells. Nat Cell Biol. 2007; 9(12):1428-1435.
30. Morin RD, et al. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res. 2008;18(4):610-621.
31. Ivey KN, et al. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell. 2008;2(3):219-229.
32. Ventura A, et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell. 2008;132(5):875-886.
33. Rosa A, Spagnoli FM, Brivanlou AH. The miR-430/427/302 family controls mesendodermal fate specification via species-specific target selection. Dev Cell. 2009;16(4):517-527.
34. Marson A, et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell. 2008;134(3):521-533.
35. Boyer LA, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 2005; 122(6):947-956.
36. Abu-Issa R, Smyth G, Smoak I, Yamamura K, Meyers EN. Fgf8 is required for pharyngeal arch and cardiovascular development in the mouse. Development. 2002;129(19):4613-4625.
37. Liao J, Aggarwal VS, Nowotschin S, Bondarev A, Lipner S, Morrow BE. Identification of downstream genetic pathways of Tbx1 in the second heart field. Dev Biol. 2008;316(2):524-537.
38. Ryckebusch L, et al. Retinoic acid deficiency alters second heart field formation. Proc Natl Acad Sci U S A. 2008;105(8):2913-2918.
39. Rochais F, et al. Hes1 is expressed in the second heart field and is required for outflow tract development. PLoS ONE. 2009;4(7):e6267.
40. von Both I, et al. Foxh1 is essential for development of the anterior heart field. Dev Cell. 2004;7(3):331-345.
41. Chan JY, et al. Identification of cardiac-specific myosin light chain kinase. Circ Res. 2008;102(5):571-580.
42. Tomescot A, et all. Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats. Stem Cells. 2007; 25(9):2200-2205.
43. Colucci F, et al. Dissecting NK cell development using a novel alymphoid mouse model: investigating the role of the c-abl proto-oncogene in murine NK cell differentiation. J Immunol. 1999; 162(5):2761-2765.
44. Sumi T, Tsuneyoshi N, Nakatsuji N, Suemori H. Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/{beta}-catenin, Activin/Nodal and BMP signaling. Development. 2008;135(17):2969-2979.
45. Naito AT, et al. Developmental stage-specific biphasic roles of Wnt/beta-catenin signaling in cardiomyogenesis and hematopoiesis. Proc Natl Acad Sci U S A. 2006;103(52):19812-19817.
46. Zeineddine D, et al. Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development. Dev Cell. 2006;11(4):535-546.
47. Boyer LA, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 2005;122(6):947-956.
48. Greer Card DA, et al. Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol. 2008;28(20):6426-6438.
49. Kulisz A, Simon HG. An evolutionarily conserved nuclear export signal facilitates cytoplasmic localization of the Tbx5 transcription factor. Mol Cell Biol. 2008;28(5):1553-1564.
50. Bernex F, De Sepulveda P, Kress C, Elbaz C, Delouis C, Panthier JJ. Spatial and temporal patterns of c-kitexpressing cells in WlacZ/+ and WlacZ/WlacZ mouse embryos. Development. 1996;122(10):3023-3033.
51. Cai CL, et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell. 2003;5(6):877-889.
52. Waldo KL, et al. Conotruncal myocardium arises from a secondary heart field. Development. 2001; 128(16):3179-3188.
53. Morikawa Y, Cserjesi P. Cardiac neural crest expression of Hand2 regulates outflow and second heart field development. Circ Res. 2008;103(12):1422-1429.
54. Stottmann RW, Choi M, Mishina Y, Meyers EN, Klingensmith J. BMP receptor IA is required in mammalian neural crest cells for development of the cardiac outflow tract and ventricular myocardium. Development. 2004;131(9):2205-2218.
55. Tomita Y, et al. Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart. J Cell Biol. 2005;170(7):1135- 1146.
56. Seguchi O, et al. A cardiac myosin light chain kinase regulates sarcomere assembly in the vertebrate heart. J Clin Invest. 2007;117(10):2812-2824.
57. Meilhac SM, Esner M, Kelly RG, Nicolas JF, Buckingham ME. The clonal origin of myocardial cells in different regions of the embryonic mouse heart. Dev Cell. 2004;6(5):685-698.
58. Maherali N, Ahfeldt T, Rigamonti A, Utikal J, Cowan C, Hochedlinger K. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell. 2008; 3(3):340-345.
59. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45.
60. Rucker-Martin C, Pecker F, Godreau D, Hatem SN. Dedifferentiation of atrial myocytes during atrial fibrillation: role of fibroblast proliferation in vitro. Cardiovasc Res. 2002;55(1):38-52.
61. Nelson JD, Denisenko O, Bomsztyk K. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat Protoc. 2006;1(1):179-185.
62. Dahl JA, Collas P. Q2ChIP, a quick and quantitative chromatin immunoprecipitation assay, unravels epigenetic dynamics of developmentally regulated genes in human carcinoma cells. Stem Cells. 2007; 25(4):1037-1046.
63. Li Z, et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci U S A. 2008;105(40):15535-15540.